Search

everythinglearnresearchcommunity

for

Search:↓

Chronic telogen effluvium is a condition where there is prolonged shedding of hair.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Thyroid problems can cause hair loss and change hair texture.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Etretinate treatment changed hair growth patterns in many patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Minoxidil treatment can reduce hair shedding, increase hair volume, and even change hair color in patients with loose anagen hair syndrome.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Colchicine causes hair loss by damaging hair follicles.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.